The company has a quick ratio of 3.11, a current ratio of 3.62 and a debt-to-equity ratio of 0.41. Shares of NASDAQ NVDA opened at $118.88 on Tuesday.
Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $212.76. Eleven equities research analysts have rated the stock with a hold rating, twenty-four have assigned a buy rating and one has issued a strong buy rating to the company's stock. Finally, The Goldman Sachs Group dropped their target price on shares of NVIDIA from $192.00 to $166.00 in a report on Friday, July 15th. They set a "hold" rating and a $165.00 price objective on the stock.
Stifel Nicolaus initiated coverage on shares of NVIDIA in a research report on Wednesday, September 7th. Jefferies Financial Group reduced their price objective on shares of NVIDIA from $370.00 to $280.00 in a research report on Thursday, August 25th. Credit Suisse Group set a $205.00 price objective on shares of NVIDIA in a research report on Wednesday, August 31st. began coverage on shares of NVIDIA in a research report on Wednesday, October 12th. Other research analysts also recently issued reports about the stock.
Is NVIDA Stock Getting Too Cheap to Ignore?. Deutsche Bank Aktiengesellschaft's target price points to a potential upside of 17.77% from the company's current price. NVIDIA ( NASDAQ:NVDA - Get Rating) had its target price reduced by Deutsche Bank Aktiengesellschaft from $165.00 to $140.00 in a report issued on Tuesday, The Fly reports. 7 Mid-Cap Stocks That Can be the Perfect Fit at Any Time. 7 Stocks to Buy to Outrun Rising Interest Rates. 7 Sports Betting Stocks to Buy for Their Long-Term Possibilities. 7 Water Stocks to Buy as the World Dries Up. 7 Solar Stocks Leading the Clean Energy Boom. 7 Railroad Stocks to Keep Your Portfolio Chugging Along. 7 Agricultural Stocks to Buy to Keep Your Portfolio Well Fed. 7 Streaming Stocks that Will Stand up to Streaming Fatigue. 7 Cash Rich Stocks That Offer Safety in Any Market. 7 Small-Cap Stocks That Could Rocket Higher in 2023. Krispy Kreme Deal with McDonalds Could Be a Gamechanger. 
Why is AbbVie Stock Falling, but Still Good Long-Term?. Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio. Morgan Stanley Still Has Double Digit Upside. Is onsemi On Target For A New Record High Share Price?. Why Investors Are Suddenly Excited About Vaxcyte. Saia Stock Is Ready To Switch Gears And Move Higher. Is The Meta Platforms Stock Meltdown a Rare Buying Opportunity?. As Mega Caps Get Crushed, This Mid Cap Tech Stock Is Crushing It. Here’s Why Harley-Davidson is Roaring Higher. The Trader's Guide to Equities Research.
0 kommentar(er)
